{"data":{"id":"us-ok/okla.-stat.-tit.-59-59-567.4a","jurisdiction":"us-ok","citation":"Okla. Stat. tit. 59, § 59-567.4a","heading":"Prescriptive authority recognition - Rules","body":"The Oklahoma Board of Nursing may grant prescriptive authority\n\nthrough the Advanced Practice Registered Nurse license to Certified\n\nNurse Practitioners, Clinical Nurse Specialists, and Certified\n\nNurse-Midwives who meet the requirements for prescriptive authority\n\nidentified by law and in the Board’s rules. The rules regarding\n\nprescriptive authority recognition promulgated by the Oklahoma Board\n\nof Nursing pursuant to this section, Section 567.3a of this title,\n\nand Sections 1 and 4 of this act shall:\n\n1. Define the procedure for documenting supervision by a\n\nsupervising physician, as defined in Section 567.3a of this title,\n\nof a Certified Nurse Practitioner, Clinical Nurse Specialist, or\n\nCertified Nurse-Midwife who has not obtained independent\n\nprescriptive authority under Section 1 of this act. Such procedure\n\nshall include a written supervision agreement that meets the\n\nrequirements of Section 4 of this act. The supervision agreement\n\nshall be part of the initial application and the renewal application\n\nsubmitted to the Board for recognition for prescriptive authority\n\nfor the Advanced Practice Registered Nurse. Changes to the\n\nsupervision agreement shall be filed with the Board within thirty\n\n(30) days of the change and shall be effective on filing;\n\n2. Define procedures for assessing the qualifications of\n\napplicants for independent prescriptive authority as provided by\n\nSection 1 of this act;\n\n3. Define minimal requirements for initial application for\n\nprescriptive authority which shall include, but not be limited to,\n\nevidence of completion of a minimum of forty-five (45) contact hours\n\nor three (3) academic credit hours of education in\n\npharmacotherapeutics, clinical application, and use of\n\npharmacological agents in the prevention of illness, and in the\n\nrestoration and maintenance of health in a program beyond basic\n\nregistered nurse preparation, approved by the Board. Such contact\n\nhours or academic credits shall be obtained within a time period of\n\nthree (3) years immediately preceding the date of application for\n\nprescriptive authority;\n\n4. Define minimal requirements for application for renewal of\n\nprescriptive authority which shall include, but not be limited to,\n\ndocumentation of a minimum of:\n\na. fifteen (15) contact hours or one (1) academic credit\n\nhour of education in pharmacotherapeutics, clinical\n\napplication, and use of pharmacological agents in the\n\nprevention of illness, and in the restoration and\n\nmaintenance of health in a program beyond basic\n\nregistered nurse preparation, and\n\nb. two (2) hours of education in pain management or two\n\n(2) hours of education in opioid use or addiction,\n\nunless the Advanced Practice Registered Nurse has\n\ndemonstrated to the satisfaction of the Board that the\n\nAdvanced Practice Registered Nurse does not currently\n\nhold a valid federal Drug Enforcement Administration\n\nregistration number,\n\napproved by the Board, within the two-year period immediately\n\npreceding the effective date of application for renewal of\n\nprescriptive authority. Such minimal requirements for renewal of\n\nprescriptive authority for an Advanced Practice Registered Nurse who\n\nhas obtained independent prescriptive authority under Section 1 of\n\nthis act shall include, but not be limited to, documentation that\n\nthe Advanced Practice Registered Nurse has successfully earned at\n\nleast forty (40) hours of Category I continuing medical education\n\nhours within the two-year period immediately preceding the effective\n\ndate of application for renewal of independent prescriptive\n\nauthority, which may include the continuing education described in\n\nsubparagraphs a and b of this paragraph if such continuing education\n\nmeets the criteria for Category I continuing medical education;\n\n5. Require that an Advanced Practice Registered Nurse\n\ndemonstrates successful completion of a master’s degree or higher in\ne effective\n\ndate of application for renewal of independent prescriptive\n\nauthority, which may include the continuing education described in\n\nsubparagraphs a and b of this paragraph if such continuing education\n\nmeets the criteria for Category I continuing medical education;\n\n5. Require that an Advanced Practice Registered Nurse\n\ndemonstrates successful completion of a master’s degree or higher in\n\none of the following Advanced Practice Registered Nurse roles:\n\na. Certified Nurse Practitioner,\n\nb. Clinical Nurse Specialist, or\n\nc. Certified Nurse-Midwife,\n\nin order to be eligible for initial application for prescriptive\n\nauthority under the provisions of the Oklahoma Nursing Practice Act;\n\n6. Define the method for communicating authority to prescribe\n\nor termination of same, and the formulary to the State Board of\n\nPharmacy, all pharmacies, and all registered pharmacists;\n\n7. Define terminology used in such rules;\n\n8. Define the parameters for the prescribing practices of the\n\nAdvanced Practice Registered Nurse;\n\n9. Define the methods for termination of prescriptive authority\n\nfor the Advanced Practice Registered Nurse; and\n\n10. a. Establish a Formulary Advisory Council that shall\n\ndevelop and submit to the Board recommendations for an\n\nexclusionary formulary that shall list drugs or\n\ncategories of drugs that shall not be prescribed by an\n\nAdvanced Practice Registered Nurse recognized to\n\nprescribe by the Oklahoma Board of Nursing. The\n\nFormulary Advisory Council shall also develop and\n\nsubmit to the Board recommendations for practice-\n\nspecific prescriptive standards for each category of\n\nAdvanced Practice Registered Nurse recognized to\n\nprescribe by the Oklahoma Board of Nursing pursuant to\n\nthe provisions of the Oklahoma Nursing Practice Act.\n\nThe Board shall either accept or reject the\n\nrecommendations made by the Council. No amendments to\n\nthe recommended exclusionary formulary may be made by\n\nthe Board without the approval of the Formulary\n\nAdvisory Council.\n\nb. The Formulary Advisory Council shall be composed of\n\ntwelve (12) members as follows:\n\n(1) four members, to include a pediatrician, an\n\nobstetrician-gynecological physician, a general\n\ninternist, and a family practice physician;\n\nprovided, that three of such members shall be\n\nappointed by the Oklahoma State Medical\n\nAssociation, and one shall be appointed by the\n\nOklahoma Osteopathic Association,\n\n(2) four members who are registered pharmacists,\n\nappointed by the Oklahoma Pharmacists\n\nAssociation, and\n\n(3) four members, one of whom shall be a Certified\n\nNurse Practitioner, one of whom shall be a\n\nClinical Nurse Specialist, one of whom shall be a\n\nCertified Nurse-Midwife, and one of whom shall be\n\na current member of the Oklahoma Board of\n\nNursing, all of whom shall be appointed by the\n\nOklahoma Board of Nursing.\n\nc. All professional members of the Formulary Advisory\n\nCouncil shall be in active clinical practice, at least\n\nfifty percent (50%) of the time, within their defined\n\narea of specialty. The members of the Formulary\n\nAdvisory Council shall serve at the pleasure of the\n\nappointing authority for a term of three (3) years.\n\nThe terms of the members shall be staggered. Members\n\nof the Council may serve beyond the expiration of\n\ntheir term of office until a successor is appointed by\n\nthe original appointing authority. A vacancy on the\n\nCouncil shall be filled for the balance of the\n\nunexpired term by the original appointing authority.\n\nd. Members of the Council shall elect a chair and a vice\n\nchair from among the membership of the Council. For\n\nthe transaction of business, at least seven members,\n\nwith a minimum of two members present from each of the\n\nidentified categories of physicians, pharmacists, and\n\nAdvanced Practice Registered Nurses, shall constitute\n\na quorum. The Council shall recommend and the Board\n\nshall approve and implement an initial exclusionary\nct a chair and a vice\n\nchair from among the membership of the Council. For\n\nthe transaction of business, at least seven members,\n\nwith a minimum of two members present from each of the\n\nidentified categories of physicians, pharmacists, and\n\nAdvanced Practice Registered Nurses, shall constitute\n\na quorum. The Council shall recommend and the Board\n\nshall approve and implement an initial exclusionary\n\nformulary on or before January 1, 1997. The Council\n\nand the Board shall annually review the approved\n\nexclusionary formulary and shall make any necessary\n\nrevisions utilizing the same procedures used to\n\ndevelop the initial exclusionary formulary.","path":["OK Code","Title 59"],"source_url":"https://www.oklegislature.gov/OK_Statutes/CompleteTitles/os59.pdf","current_through":"2026-08-14","vintage":"open-us-law v2026.08, retrieved 2026-09-14","retrieved_at":"2026-09-14T18:32:36Z","sha256":"eb1dc2c9848a1df30e783a77a98afb5449df960e03631231da686b74de7629f4","source_id":"us-ok","stale":false,"prev":"us-ok/okla.-stat.-tit.-59-59-567.4","next":"us-ok/okla.-stat.-tit.-59-59-567.4b"},"notice":"GroundRules: Original legal text. Not legal advice."}